Are you Dr. Steinberg?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 38 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
830 Harrison Ave
Moakley, 3rd Floor
Boston, MA 02118Phone+1 617-638-6428Fax+1 617-638-5756
Summary
- Dr. Martin Steinberg, MD is a hematologist in Boston, Massachusetts. He is currently licensed to practice medicine in Massachusetts. He is a Professor at Boston University School of Medicine.
Education & Training
Tufts Medical CenterResidency, Internal Medicine, 1966 - 1968
NYU Grossman School of MedicineInternship, Transitional Year, 1962 - 1963
Tufts University School of MedicineClass of 1962
Certifications & Licensure
MA State Medical License 1965 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 1979
Publications & Presentations
PubMed
- 69 citationsGenetic modifiers of the severity of sickle cell anemia identified through a genome‐wide association studyPaola Sebastiani, Nadia Solovieff, Stephen W. Hartley, Jacqueline N. Milton, Alberto Riva
American Journal of Hematology. 2009-10-23 - 375 citationsIntravascular hemolysis and the pathophysiology of sickle cell diseaseGregory J. Kato, Martin H. Steinberg, Mark T. Gladwin
The Journal of Clinical Investigation. 2017-03-01 - 22 citationsFetal hemoglobin in sickle cell anemia: The Arab-Indian haplotype and new therapeutic agents.Alawi Habara, Elmutaz M. Shaikho, Martin H. Steinberg
American Journal of Hematology. 2017-08-17
Press Mentions
What if a CRISPR Cure Isn’t Such an Easy Choice?November 9th, 2023- FDA Approves Two Gene Therapies for Sickle Cell, Including First CRISPR-Based MedicineDecember 12th, 2023
- FDA Weighs Gene-Editing Treatments’ Curative Possibilities Against Potential RisksDecember 12th, 2023
Grant Support
- Globin Gene Expression In Sickle Cell Genotype-Specific IPS CellsNational Heart, Lung, And Blood Institute2011
- Sickle Cell ScholarNational Heart, Lung, And Blood Institute2008–2011
- Administrative CoreNational Heart, Lung, And Blood Institute2008–2011
- Boston Comprehensive Sickle Cell CenterNational Heart, Lung, And Blood Institute2003–2011
- Genetic Diversity Of Sickle Cell AnemiaNational Heart, Lung, And Blood Institute2009–2010
- Genome-Wide Association Studies In Sickle Cell Anemia And In CentenariansNational Heart, Lung, And Blood Institute2007–2010
- Genetic Modulation Of Sickle Cell DiseaseNational Heart, Lung, And Blood Institute2006–2010
- Genetic Modulation Of Sickle Cell AnemiaFogarty International Center2006–2008
- Pulse Arginine Butyrate In Sickle Cell DiseaseNational Center For Research Resources2007
- Research Scholar ProgramNational Heart, Lung, And Blood Institute2004–2007
- Core--Inter Center Collaborative Clinical ResearchNational Heart, Lung, And Blood Institute2004–2007
- Core--Clinical CoreNational Heart, Lung, And Blood Institute2004–2007
- Determinants Of Hbf Response To HydroxyureaNational Heart, Lung, And Blood Institute2002–2005
- Genetic Modulation Of Sickle Cell AnemiaNational Heart, Lung, And Blood Institute2001–2005
- Comprehensive Sickle Cell CenterNational Heart, Lung, And Blood Institute2001–2002
